Australia's Mayne Pharma surges on $408 million takeover by Hungary's Gedeon Richter
** Shares of Australia's Mayne Pharma MYX.AX soar as much as 86% to A$5.970, marking their biggest intraday pct gain ever
** Shares hit their highest level since late November 2025
** Pharma firm enters scheme implementation deed with Hungarian drugmaker Gedeon Richter GDRB.BU under which the latter will buy 100% of MYX
** Offer values the company's equity at about A$604 million ($407.76 million) and represents a 99.4% premium to its last close on November 16
** Co says scheme is subject to completing sale of its international business segment to Evaris Pharma
** More than 1.2 million shares change hands, about 4.6x the 30-day average
** YTD, stock up 86.8%, including session's moves
($1 = 1.4813 Australian dollars)